FDVIX
Price
$25.75
Change
+$1.87 (+7.83%)
Updated
Apr 9 closing price
Net Assets
1.39B
RERAX
Price
$48.48
Change
+$2.30 (+4.98%)
Updated
Apr 9 closing price
Net Assets
110.84B
Ad is loading...

FDVIX vs RERAX

Header iconFDVIX vs RERAX Comparison
Open Charts FDVIX vs RERAXBanner chart's image
Fidelity Advisor Diversified Intl I
Price$25.75
Change+$1.87 (+7.83%)
VolumeN/A
Net Assets1.39B
American Funds Europacific Growth R1
Price$48.48
Change+$2.30 (+4.98%)
VolumeN/A
Net Assets110.84B
FDVIX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDVIX vs. RERAX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDVIX is a Hold and RERAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 111B vs. FDVIX (1.39B). FDVIX pays higher dividends than RERAX: FDVIX (1.70) vs RERAX (0.46). FDVIX was incepted earlier than RERAX: FDVIX (26 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FDVIX (0.87). FDVIX is a more actively managed with annual turnover of: 33.00 vs. RERAX (30.00). FDVIX has a lower initial minimum investment than RERAX: FDVIX (0) vs RERAX (250). FDVIX annual gain was more profitable for investors over the last year : -10.70 vs. RERAX (-16.05). FDVIX return over 5 years is better than : 20.23 vs. RERAX (9.69).
FDVIXRERAXFDVIX / RERAX
Total Expense Ratio0.871.5755%
Annual Report Gross Expense Ratio0.871.5755%
Fund Existence26 years23 years-
Gain YTD-5.910-8.42870%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B111B1%
Annual Yield % from dividends1.700.46373%
Returns for 1 year-10.70-16.0567%
Returns for 3 years-4.89-11.4343%
Returns for 5 years20.239.69209%
Returns for 10 years16.59-5.13-323%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GENK4.640.44
+10.48%
GEN Restaurant Group
LNTH100.166.75
+7.23%
Lantheus Holdings
TSHA1.210.08
+6.64%
Taysha Gene Therapies
CCEP85.053.21
+3.92%
Coca-Cola Europacific Partners plc
INVA17.320.07
+0.41%
Innoviva